Kyle Kleinbeck

Scientist II, Formulation Technology

Population Council

Dr. Kyle Kleinbeck is a pharmaceutical development scientist focused on sexual and reproductive health with 13 years of experience in the industry, nearly all of which has been spent developing drugs and medical devices with non-profit, mission-based organizations. Dr. Kleinbeck received his BS in Pharmacology & Toxicology and a PhD in Pharmaceutical Sciences from the University of Wisconsin-Madison. His career has focused on formulation and manufacturing process development for active pharmaceutical ingredients, drug products, and medical devices with Patheon Pharmaceuticals, International Partnership for Microbicides, and the Population Council.

Since joining the Population Council in New York in 2012, Dr. Kleinbeck has specialized in the development of HIV prevention and contraception products such as intravaginal rings, gels, and fast-dissolving inserts. He is authored on over 25 peer-reviewed journal publications and has been a leading scientist in the introduction of 5 novel small molecule and protein products into initial clinical trials. Dr. Kleinbeck will be discussing a new HIV-prevention technology under development at the Population Council which employs therapeutic proteins produced via plant-based biomanufacturing at SwiftPharma for drug products with global reach.